The 21st ESTP’s (European Society of Toxicology Pathology) Annual Congress (2024) included a 3-hour scientific session on developmental neurotoxicity (DNT) as applied to chemical safety assessments. Key concepts of this session were to provide an introduction to public concerns around this endpoint, a status update on practical aspects of DNT studies, insights into the use of DNT studies within a regulatory context, as well as some pointers on how to evaluate specific parameters. Understanding the biological and technical variability in performing neuropathology examinations (such as morphometric evaluation) is critical during the course of DNT evaluation. Using thyroid hormone disruption as an example, challenges and pitfalls impacting data interpretation were discussed. Results from the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Thyroid Task Force regarding thyroid hormone–related neurodevelopmental toxicity in humans and rodents were presented. Histopathological findings in the brain and potential changes in the cochlea of pups associated with thyroid hormone imbalance in dams during pregnancy were shown. A case presentation from an Extended One-Generation Reproductive Toxicity Study (EOGRTS) showing histopathological findings in the absence of changes with morphometric endpoints was included. In conclusion, all session participants underscored the need for integrated data evaluation for DNT risk assessment.
BartschRBrinkmannBJahnkeG, et al. Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances. Regul Toxicol Pharmacol. 2018;98:199-208. doi:10.1016/j.yrtph.2018.07.025.
2.
BazeAWissLHorbalLBiemelKAsselinLRichertL. Comparison of in vitro thyroxine (T4) metabolism between Wistar rat and human hepatocyte cultures. Toxicol Vitro. 2024;96:105763. doi:10.1016/j.tiv.2023.105763.
3.
CainelliEBisiacchiP. Neurodevelopmental disorders: past, present, and future. Children (Basel). 2022;10(1):31. doi:10.3390/children10010031.
4.
CroftonKMBassanABehlM, et al. Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches. Comput Toxicol. 2022;22:100223. doi:10.1016/j.com tox.2022.100223.
European Chemical Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint Research Centre (JRC); AnderssonNArenaMAuteriD, et al. Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No1107/2009. EFSA J. 2018;16(6):e05311. doi:10.2903/j.efsa.2018.5311.
8.
European Union. Commission regulation (EU) 2018/605 of 19 April 2018 amending annex II to regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties (Text with EEA relevance). C/2018/2229. Published 2018. Accessed January 2, 2025. http://data.europa.eu/eli/reg/2018/605/oj.
9.
European Union. Commission delegated regulation (EU) 2017/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 of the European Parliament and Council (Text with EEA relevance) C/2017/5467. Published 2017. Accessed January 2, 2025. http://data.europa.eu/eli/reg_del/2017/2100/oj
10.
FosterJRTinwellHMelching-KollmussS. A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer. Arch Toxicol. 2021;95(3):807-836. doi:10.1007/s00204-020.
11.
FrancésLQuinteroJFernándezA, et al. Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria. Child Adolesc Psychiatry Ment Health. 2022;16(1):27. doi:10.1186/s13034-022-00462-1.
12.
GarmanRHLiAAKaufmannWAuerRNBolonB. Recommended methods for brain processing and quantitative analysis in rodent developmental neurotoxicity studies. Toxicol Pathol. 2016;44(1):14-42. doi:10.1177/0192623315596858.
13.
GoodmanJHGilbertME. Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: a model of cortical dysplasia. Endocrinology. 2007;148(6):2593-2597. doi:10.1210/en.2006-1276.
14.
GrandjeanPLandriganPJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13(3):330-338. doi:10.1016/S1474-4422(13)70278.
JubergDRFoxDAForcelliPA, et al. A perspective on in vitro developmental neurotoxicity test assay results: an expert panel review. Regul Toxicol Pharmacol. 2023;143:105444. doi:10.1016/j.yrtph.2023.105444.
17.
Juric-SekharGHevnerRF. Malformations of cerebral cortex development: molecules and mechanisms. Annu Rev Pathol. 2019;14:293-318. doi:10.1146/annurev-pathmechdis.
18.
KaufmannW. Pathology methods in nonclinical neurotoxicity studies: the developing central nervous system. In: BolonBButtMT, eds. Fundamental Neuropathology for Pathologists and Toxicologists: Principles and Techniques. Hoboken, NJ: John Wiley & Sons; 2011:339-363.
19.
KaufmannWGrötersS. Developmental neuropathology in DNT-studies–a sensitive tool for the detection and characterization of developmental neurotoxicants. Reprod Toxicol. 2006;22(2):196-213. doi:10.1016/j.repro tox.2006.04.021.
20.
MakrisSLRaffaeleKAllenS, et al. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect. 2009;117(1):17-25. doi:10.1289/ehp.11447.
21.
ManoMTPotterBJBellingGBChavadejJHetzelBS. Fetal brain development in response to iodine deficiency in a primate model (Callithrix jacchus jacchus). J Neurol Sci. 1987;79(3):287-300. doi:10.1016/0022-510x(87)90236.
22.
MartyMSSauerUGCharltonA, et al. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny-part III: how is substance-mediated thyroid hormone imbalance in pregnant/lactating rats or their progeny related to neurodevelopmental effects?Crit Rev Toxicol. 2022;52(7):546-617. doi:10.1080/10408444.2022.2130166.
23.
MasjosthusmannSBlumJBartmannK, et al. Establishment of an a priori protocol for the implementation and interpretation of an in-vitro testing battery for the assessment of developmental neurotoxicity. EFSA Supporting Publication 2020. Published 2020. Accessed January 2, 2025. https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/sp.efsa.2020.EN-1938
24.
Melching-KollmussSBotheKCharltonA, et al. Towards a science—based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny—Part IV: the ECETOC and CLE proposal for a thyroid function-related neurodevelopmental toxicity testing and assessment scheme (Thyroid-NDT-TAS). Crit Rev Toxicol. 2023;53(6):339-371. doi:10.1080/10408444.2023.2231033.
25.
Melching-KollmussSSauerUGSGattoVStinchcombeSTinwellH (2025) A proposal of criteria to support the EU classificaiton on endocrine disruption for the thyroid modality and their applicaiton to four data-rich case studies. Archives of Toxicology, doi.org/10.1007/s00204-025-04037-9
26.
MinamiKSutoHSatoA, et al. Feasibility study for a downsized comparative thyroid assay with measurement of brain thyroid hormones and histopathology in rats: case study with 6-propylthiouracil and sodium phenobarbital at high dose. Regul Toxicol Pharmacol. 2023;137:105283. doi:10.1016/j.yrtph.2022.105283.
27.
NoyesPDFriedmanKPBrowneP, et al. Evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches. Environ Health Perspect. 2019;127(9):95001. doi:10.1289/EHP5297.
28.
OECD. Test No. 426: Developmental Neurotoxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing; 2007. Accessed January 2, 2025. https://doi.org/10.1787/9789264067394-en
29.
OECD. Test No. 443: Extended One-generation Reproductive Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing; 2018. Accessed January 2, 2025. https://doi.org/10.1787/9789264185371-en
SauerUGAsiimweABothamPA, et al. Toward a science—based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny—part I: which parameters from human studies are most relevant for toxicological assessments?Crit Rev Toxicol. 2020;50(9):740-763. doi:10.1080/10408444.2020.1839380.
32.
ShibutaniMWooGHFujimotoH, et al. Assessment of developmental effects of hypothyroidism in rats from in utero and lactation exposure to anti-thyroid agents. Reprod Toxicol. 2009;28(3):297-307. doi:10.1016/j.reprotox.2009.04.011.
33.
SmirnovaLHogbergHTLeistMHartungT. Revolutionizing developmental neurotoxicity testing—a journey from animal models to advanced in vitro systems. ALTEX. 2024;41(2):152-178. doi:10.14573/altex.2403281.
34.
WatrinFManentJBCardosoCRepresaA. Causes and consequences of gray matter heterotopia. CNS Neurosci Ther. 2015;21(2):112-122. doi:10.1111/cns.12322.
